RNN - Rexahn Pharmaceuticals, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts3332
Avg. Estimate-0.85-0.98-3.64-4.15
Low Estimate-0.95-1.1-3.71-4.32
High Estimate-0.7-0.86-3.55-3.99
Year Ago EPS-1.44-2.04-5.28-3.64
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts2221
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-2.19-2.04-1.56-0.93
EPS Actual-1.44-2.04-1.08-0.62
Difference0.7500.480.31
Surprise %34.20%0.00%30.80%33.30%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.85-0.98-3.64-4.15
7 Days Ago-0.85-0.98-3.64-4.15
30 Days Ago-1.02-1.09-4.14-5
60 Days Ago-0.09-0.09-0.36-0.42
90 Days Ago-0.09-0.09-0.36-0.42
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days2221
Up Last 30 Days2221
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRNNIndustrySectorS&P 500
Current Qtr.41.00%N/AN/A-0.00
Next Qtr.52.00%N/AN/A0.08
Current Year31.10%N/AN/A0.03
Next Year-14.00%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A